- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · May 6, 2024 | 8.27M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 8.92M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 8.91M sh |
| Shares Diluted restated | Q2 2024 · Mar 31, 2023 | 4.52M sh |
| Shares Diluted restated | Q2 2024 · Mar 31, 2023 | 4.14M sh |
| Capex | Q2 2024 · Mar 31, 2024 | $292K |
| Capex | Q2 2024 · Mar 31, 2023 | $1.53M |
| Operating Cash Flow | Q2 2024 · Mar 31, 2024 | −$12.69M |
| Operating Cash Flow restated | Q2 2024 · Mar 31, 2023 | −$22.79M |
| Long Term Debt | Q2 2024 · Mar 31, 2024 | $3.76M |
| Cash And Equivalents | Q2 2024 · Mar 31, 2024 | $11.5M |
| Cash And Equivalents | Q2 2024 · Sep 30, 2023 | $26.21M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $67.34M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $80.29M |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $22.54M |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $28.79M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $53.66M |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $63.62M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $73.78M |
| Current Assets | Q2 2024 · Sep 30, 2023 | $92.39M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $121M |
| Total Assets | Q2 2024 · Sep 30, 2023 | $143.91M |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | −$0.95 |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | −$1.59 |
| Eps Diluted restated | Q2 2024 · Mar 31, 2023 | −$2.70 |
| Eps Diluted restated | Q2 2024 · Mar 31, 2023 | −$5.78 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | −$0.95 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | −$1.59 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$2.70 |
| Eps Basic restated | Q2 2024 · Mar 31, 2023 | −$5.78 |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $6.04M |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $12.65M |
| Sga Expense restated | Q2 2024 · Mar 31, 2023 | $9.09M |
| Sga Expense restated | Q2 2024 · Mar 31, 2023 | $18.38M |
| Rd Expense | Q2 2024 · Mar 31, 2024 | $3.73M |
| Rd Expense | Q2 2024 · Mar 31, 2024 | $7.34M |
| Rd Expense restated | Q2 2024 · Mar 31, 2023 | $4.88M |
| Rd Expense restated | Q2 2024 · Mar 31, 2023 | $9.1M |
| Net Income | Q2 2024 · Mar 31, 2024 | −$8.5M |
| Net Income | Q2 2024 · Mar 31, 2024 | −$14.17M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$12.23M |
| Net Income | Q2 2024 · Mar 31, 2023 | −$23.92M |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$7.62M |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$11.93M |
| Operating Income restated | Q2 2024 · Mar 31, 2023 | −$9.13M |
| Operating Income restated | Q2 2024 · Mar 31, 2023 | −$17.1M |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $3.25M |
| Gross Profit | Q2 2024 · Mar 31, 2024 | $9.34M |
| Gross Profit restated | Q2 2024 · Mar 31, 2023 | $4.86M |
| Gross Profit restated | Q2 2024 · Mar 31, 2023 | $9.24M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $16.39M |
| Cost Of Revenue | Q2 2024 · Mar 31, 2024 | $34.42M |
| Cost Of Revenue restated | Q2 2024 · Mar 31, 2023 | $19.39M |
| Cost Of Revenue restated | Q2 2024 · Mar 31, 2023 | $34.99M |
| Revenue | Q2 2024 · Mar 31, 2024 | $19.63M |
| Revenue | Q2 2024 · Mar 31, 2024 | $43.76M |
| Revenue restated | Q2 2024 · Mar 31, 2023 | $24.25M |
| Revenue restated | Q2 2024 · Mar 31, 2023 | $44.23M |